Our research focused on glucokinase (which has a vital role in glucose metabolism and as a rate limiting enzyme in the development of type 2 diabetes) as a molecular target for the identification of anti-diabetic components among the identified compounds [28]. This evidence concerns the gene GCK and type 2 diabetes mellitus.